These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16920540)

  • 1. Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART).
    Lin AL; Johnson DA; Sims CA; Stephan KT; Yeh CK
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):318-24. PubMed ID: 16920540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary secretory leukocyte protease inhibitor increases in HIV infection.
    Lin AL; Johnson DA; Stephan KT; Yeh CK
    J Oral Pathol Med; 2004 Aug; 33(7):410-6. PubMed ID: 15250833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
    Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
    J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients.
    Jainkittivong A; Lin AL; Johnson DA; Langlais RP; Yeh CK
    Oral Dis; 2009 Apr; 15(3):229-34. PubMed ID: 19207880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants.
    Navazesh M; Mulligan R; Barrón Y; Redford M; Greenspan D; Alves M; Phelan J;
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):693-8. PubMed ID: 12789150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection, as opposed to antiretroviral therapy, does not cause changes in the concentration levels of specific salivary electrolytes.
    Biocina-Lukenda D; Blazić-Potocki Z; Lukenda J; Potocki-Karacić T
    Coll Antropol; 2009 Mar; 33(1):93-7. PubMed ID: 19408610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in salivary function in early HIV infection.
    Lin AL; Johnson DA; Stephan KT; Yeh CK
    J Dent Res; 2003 Sep; 82(9):719-24. PubMed ID: 12939357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcirculatory vascular dysfunction in HIV-1 infected patients receiving highly active antiretroviral therapy.
    Palios J; Ikonomidis I; Lekakis J; Tsiodras S; Poulakou G; Antoniadou A; Panagopoulos P; Papadopoulos A; Giamarellou H; Anastasiou-Nana M; Kremastinos D
    Microcirculation; 2010 May; 17(4):303-10. PubMed ID: 20536743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary anticandidal activity and saliva composition in an HIV-infected cohort.
    Lin AL; Johnson DA; Patterson TF; Wu Y; Lu DL; Shi Q; Yeh CK
    Oral Microbiol Immunol; 2001 Oct; 16(5):270-8. PubMed ID: 11555303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodontal conditions and distribution of Prevotella intermedia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in HIV-infected patients undergoing anti-retroviral therapy and in an HIV-seronegative group of the Venezuelan population.
    Brito A; Escalona LA; Correnti M; Perrone M; Bravo IM; Tovar V
    Acta Odontol Latinoam; 2008; 21(1):89-96. PubMed ID: 18841752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era.
    Nittayananta W; Chanowanna N; Jealae S; Nauntofte B; Stoltze K
    J Oral Pathol Med; 2010 Jan; 39(1):28-34. PubMed ID: 19709350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of salivary calprotectin levels in subjects with and without oral candidiasis.
    Kleinegger CL; Stoeckel DC; Kurago ZB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jul; 92(1):62-7. PubMed ID: 11458247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.
    Manfredi R; Calza L; Chiodo F
    J Biol Regul Homeost Agents; 2006; 20(1-2):1-9. PubMed ID: 18088548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.